Precision medicine advances in treating cerebral vascular malformations: Insights into pathogenesis and therapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Jul-2025 13:10 ET (4-Jul-2025 17:10 GMT/UTC)
A groundbreaking review highlights significant advancements in the understanding and treatment of cerebral vascular malformations (CVMs), emphasizing the potential of precision medicine. Integrating genetic, molecular, and imaging insights, the study redefines therapeutic strategies for these life-altering neurological conditions.
Rewards and financial incentives are successful methods to help people quit smoking, according to a new Cochrane review co-led by a University of Massachusetts Amherst public health and health policy researcher. For the first time, the researchers also found “high-certainty evidence” that this intervention works for pregnant people as well.
In a paper published in Science Bulletin, a Chinese team of scientists revealed the complexities of hepatic SLC7A11 and the essentiality of SLC7A11-mediated nonessential amino acids in MASLD. Slc7a11 deficiency accelerated MASLD progression via classic cystine/cysteine deficiency–induced ferroptosis, while serine deficiency and a resulting impairment in de novo cysteine production were attributed to ferroptosis-induced MASLD progression in mice overexpressing hepatic Slc7a11. Researchers found that both serine supplementation and blocking ferroptosis significantly alleviated MASLD, and the serum serine/glutamate ratio might serve as a prognostic biomarker for MASLD in patients.
A new Perspective piece in The New England Journal of Medicine led by the Harvard Pilgrim Health Care Institute examined the increasing frequency of physician strikes around the globe.
The piece is one of the first to provide international lessons on balancing physician collective bargaining rights with patient protections in the U.S.
The findings underscore the urgent need for regulatory reforms to address the increasing frequency of physician strikes and ensure the sustainability of the healthcare system.
Tokyo, Japan – Researchers from Tokyo Metropolitan University have created nanostructured alumina surfaces which are strongly antibacterial but can be used to culture cells. They found that anodic porous alumina (APA) surfaces prepared using electrochemistry in concentrated sulfuric acid had unprecedented resistance to bacterial growth, but did not hamper cell cultures. The team’s technology promises to have a big impact on regenerative medicine, where high quality cell cultures without bacterial contamination may be produced without antibiotics.